tiprankstipranks
Mayne Pharma Group (AU:MYX)
ASX:MYX

Mayne Pharma Group (MYX) Cash flow

9 Followers

Mayne Pharma Group Cash Flow

AU:MYX's free cash flow for Q4 2022 was AU$―. For the 2022 fiscal year, AU:MYX's free cash flow was decreased by AU$-52.82M and operating cash flow was AU$―. See a summary of the company’s cash flow.
Cash Flow
TTM
Jun 22Jun 21Jun 20Jun 19Jun 18
Operating Cash Flow
------
Investing Cash Flow
-AU$ -28.53MAU$ -49.25MAU$ -55.87MAU$ -91.69MAU$ -118.35M
Financing Cash Flow
-AU$ 27.60MAU$ -40.44MAU$ 4.52MAU$ -15.55MAU$ 20.18M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
-AU$ 96.67MAU$ 97.98MAU$ 137.78MAU$ 89.00MAU$ 87.31M
Income Tax Paid Supplemental Data
-AU$ -7.29MAU$ -10.87MAU$ 1.79MAU$ -21.02MAU$ 7.97M
Interest Paid Supplemental Data
---AU$ 13.60MAU$ 14.56MAU$ 15.18M
Issuance Of Capital Stock
---AU$ 72.00KAU$ 7.05MAU$ 1.53M
Issuance Of Debt
-AU$ 216.30MAU$ 196.43MAU$ 211.75MAU$ 39.94MAU$ 18.84M
Repayment Of Debt
-AU$ -176.52MAU$ -222.25MAU$ -203.40MAU$ -62.55MAU$ -118.00K
Free Cash Flow
-AU$ -19.06MAU$ 33.77MAU$ 52.66MAU$ 24.69MAU$ 27.16M
Domestic Sales
------
Foreign Sales
------
Currency in AUD

Mayne Pharma Group Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis